KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.41 $2.35 Friday, 26th Apr 2024 CYCC stock ended at $1.51. This is 5.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.85% from a day low at $1.46 to a day high of $1.56.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Apr 26, 2024 $1.55 $1.56 $1.46 $1.51 179 950
Apr 25, 2024 $1.78 $1.99 $1.41 $1.60 3 457 774
Apr 24, 2024 $1.86 $2.35 $1.85 $2.30 328 254
Apr 23, 2024 $1.85 $1.85 $1.68 $1.79 28 374
Apr 22, 2024 $1.80 $1.93 $1.73 $1.75 24 019
Apr 19, 2024 $1.89 $1.95 $1.77 $1.78 10 308
Apr 18, 2024 $1.91 $1.96 $1.82 $1.85 37 738
Apr 17, 2024 $1.67 $2.09 $1.67 $1.96 113 635
Apr 16, 2024 $1.52 $1.72 $1.52 $1.67 47 375
Apr 15, 2024 $1.76 $1.84 $1.57 $1.57 38 755
Apr 12, 2024 $1.91 $1.91 $1.76 $1.76 29 642
Apr 11, 2024 $2.00 $2.05 $1.91 $1.94 24 157
Apr 10, 2024 $2.09 $2.11 $1.95 $2.05 38 651
Apr 09, 2024 $2.07 $2.11 $2.07 $2.11 5 724
Apr 08, 2024 $2.05 $2.14 $2.05 $2.11 24 817
Apr 05, 2024 $2.21 $2.21 $2.03 $2.10 17 936
Apr 04, 2024 $2.13 $2.19 $2.13 $2.19 3 778
Apr 03, 2024 $2.15 $2.22 $2.07 $2.19 21 535
Apr 02, 2024 $2.00 $2.15 $2.00 $2.12 20 013
Apr 01, 2024 $2.20 $2.23 $2.01 $2.05 22 060
Mar 28, 2024 $2.00 $2.14 $2.00 $2.11 44 661
Mar 27, 2024 $2.09 $2.09 $1.94 $1.96 14 683
Mar 26, 2024 $2.11 $2.18 $1.86 $1.92 107 189
Mar 25, 2024 $2.14 $2.22 $2.07 $2.14 58 525
Mar 22, 2024 $2.09 $2.23 $2.07 $2.19 36 904
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT